Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing <scp>nonemergent</scp> percutaneous coronary intervention
Brian O’Neill(Henry Ford Health System), Ehtisham Mahmud(Cardiovascular Institute of the South), Amin M. Medjamia(Abiomed (United States)), Alexandra J. Lansky(Queen Mary University of London), Cindy L. Grines(Northside Hospital), Jeffrey W. Moses(Good Samaritan University Hospital), William W. O’Neill(Henry Ford Hospital), Salvatore Mannino(WellStar Kennestone Hospital), Jeffery J. Popma, Navin K. Kapur(Tufts Medical Center), E. Magnus Ohman(Duke University), Theodore Schreiber(Detroit Medical Center)
Cited by 12
Related Papers
Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery
|New England Journal of Medicine|2010|7.2k
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
|New England Journal of Medicine|2011|6.4k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients
|New England Journal of Medicine|2016|5.1k